Example: Heart Attack

Search clinical trials for: Modulation of FiO2

Total 10000 results

NCT02375646

Unknown

Hemorrhage Following Small Polyp Resection in the Colon in Anticoagulated Patients

Gastrointestinal Hemorrhage | Post Polypectomy Bleeding in Anticoagulated Patients
NCT00412958

Completed

A Study of the Safety and Efficacy of Microplasmin to Induce a Posterior Vitreous Detachment (MIVI III)

Vitrectomy
NCT00576199

Completed

A Study of Avastin (Bevacizumab) and Transarterial Chemoembolisation (TACE) Treatment in Patients With Liver Cancer

Liver Cancer
NCT01304693

Completed

ESBA1008 Safety, Tolerability and Effects in Wet Age-Related Macular Degeneration (AMD) Patients

Exudative Age-Related Macular Degeneration
NCT00712257

Terminated

Study to Evaluate the Safety and Performance of Spectranetics Laser w/Adjunct PTA and Gore Viabahn Endoprosthesis for Treatment of SFA Instent Restenosis (SALVAGE)

Restenosis
NCT01686529

Completed

Bevacizumab for Primary Pterygium Treatment

Pterygium
NCT00883623

Completed

A Trial of Treatment With Lenalidomide-Melphalan-Dexamethasone in Patients With Primary (AL) Amyloidosis (LEOMEX)

Primary Amyloidosis
NCT00769873

Terminated

Anticoagulation Post Laparoscopic Splenectomy

Portal Vein Thrombosis | Splenic Vein Thrombosis
NCT00546936

Unknown

Ranibizumab Versus PDT for Presumed Ocular Histoplasmosis

Presumed Ocular Histoplasmosis (POHS)
NCT00378872

Completed

Tranexamic Acid vs. Quixil - Reducing Blood Loss in Joint Replacement

Hemorrhage | Arthroplasty, Replacement, Knee | Arthroplasty, Replacement, Hip
NCT00187408

Completed

The D-KAF (Dalteparin in Knee-to-Ankle Fracture) Trial

Deep Vein Thrombosis | Pulmonary Embolism
NCT06881537

Recruiting

CapeOX Combined With Bevacizumab Plus Anti-PD1 Antibody as Neoadjuvant Therapy for Locally Recurrent Colorectal Cancer

Locally Recurrent Colorectal Cancer
NCT05886465

Recruiting

HAIC Plus A+T for Patients With High-risk HCC: a Single-arm Phase 2 Trial

Hepatocellular Carcinoma
NCT04356729

Active, not recruiting

A Phase II Trial of PD-L1 Therapy Combined With Anti-VEGF Therapy in Unresectable or Metastatic Melanoma

Stage IV Melanoma | Clinical Stage III Cutaneous Melanoma AJCC v8 | Unresectable Stage III Cutaneous Melanoma | Unresectable Stage IV Cutaneous Melanoma
NCT06713785

Withdrawn

Personalised Electronic Record Supported Optimisation of Amlodipine for Patients With Hypertension (PERSONAL HTN)

Hypertension
NCT03363867

Active, not recruiting

BEACON - ABC in Recurrent Platinum Resistant HGSOC (BEACON)

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Carcinoma
NCT04368546

Completed

Sunitinib Treatment on Tissue Sodium Accumulation (TSS2)

Hypertension | Renal Cell Cancer Metastatic | Sodium Imbalance
NCT01742273

Terminated

Vitamin K1 to Slow Progression of Vascular Calcification in HD Patients (VitaVasK)

Cardiovascular Diseases
NCT04111289

Unknown

Effect of Upstream High Bolus Dose of Tirofiban in Primary PCI for the Patients With STEMI on Short Term Outcome (TISP)

High Bolus Dose of Tirofiban
NCT02890875

Terminated

Efficacy and Safety of Ethanol Lock Therapy for the Prevention of Central Line-associated Bloodstream Infections

Catheter-Related Infections
NCT02919371

Unknown

Combined Alternating Sunitinib and Bevacizumab (Avastin®) in Advanced Renal Cell Carcinoma (CASA)

Renal Cell Carcinoma
NCT02330783

Unknown

Efficacy and Safety of Bevacizumab Plus Sorafenib for the Third-line Treatment in Metastatic Renal Cancer Patients

Metastatic Renal Cell Carcinoma
NCT01738646

Completed

Ph II SAHA and Bevacizumab for Recurrent Malignant Glioma Patients

Malignant Glioma | Recurrent Glioblastoma Multiforme | Adult Brain Tumor
NCT02393612

Completed

Clinical Trial to Evaluate Efficacy and Safety of DP-R202 and Anplag in Patients With Artery Occlusive Disease (DAVICI)

Peripheral Arterial Disease
NCT00403156

Withdrawn

Imatinib Mesylate Combined With Intravitreal Ranibizumab in the Treatment of Choroidal Neovascularization Secondary to Age-Related Macular Degeneration

Choroidal Neovascularization
NCT00387335

Completed

Sunitinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer

Recurrent Metastatic Squamous Neck Cancer With Occult Primary | Recurrent Squamous Cell Carcinoma of the Hypopharynx | Recurrent Squamous Cell Carcinoma of the Larynx | Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity | Recurrent Squamous Cell Carcinoma of the Oropharynx | Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity | Recurrent Squamous Cell Carcinoma of the Nasopharynx | Stage IV Squamous Cell Carcinoma of the Hypopharynx | Stage IV Squamous Cell Carcinoma of the Larynx | Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity
NCT00923234

Terminated

Combination of 5-azacitidine and Lenalidomide in Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML) Myelodysplastic Syndromes (AZALE)

Myelodysplastic Syndromes | Acute Myelogenous Leukemia
NCT00265317

Completed

A Study In Patients With Non-Small Cell Lung Cancer Testing If Erlotinib Plus SU011248 (Sunitinib) Is Better Than Erlotinib Alone (SUN1058)

Carcinoma, Non-Small-Cell Lung
NCT00253344

Completed

Lenalidomide and Docetaxel in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific
NCT00352742

Terminated

A Study of ATN-224 and Bortezomib in Patients With Multiple Myeloma

Multiple Myeloma
NCT07179809

Not yet recruiting

Group-based Comprehensive Lifestyle Program for Women With Metastatic Breast Cancer

Metastatic Breast Cancer
NCT07553897

Completed

Tele-exercise Training Program for Long COVID

Long COVID
NCT06440278

Active, not recruiting

Healthy Heart Habits-2 (HHH-2)

Acute Coronary Syndrome
NCT06844474

Recruiting

A Phase II Clinical Study of SHR-1826 for Injection in Patients With NSCLC

NSCLC
NCT06717880

Recruiting

A Study of IBI363 in Combination With Bevacizumab or Furuitinib in Subjects With Advanced Colorectal Cancer

Advanced Malignancies
NCT06701656

Recruiting

JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: Bevacizumab

Acute Respiratory Distress Syndrome | ARDS | Acute Respiratory Distress Syndrome (ARDS) | ARDS (Acute Respiratory Distress Syndrome)
NCT06583330

Not yet recruiting

A Multicenter, Open-Label, Non-Inferiority Randomized Controlled Trial of Postoperative VTE Prevention in Chinese Patients After Colorectal Cancer Surgery

Colorectal Surgery | VTE (Venous Thromboembolism)
NCT06224140

Recruiting

Heparin-Free Chronic HemoDialysis Assessment (HepFreeHD)

End-Stage Renal Disease
NCT06151080

Recruiting

Lenalidomide Combined With G-CHOP in the Treatment of Newly Diagnosed DLBCL With FL

Follicular Lymphoma | DLBCL - Diffuse Large B Cell Lymphoma
NCT06132035

Recruiting

Study to Evaluate the Safety of CG-P5 Peptide Eye Drops in Patients Diagnosed With Age-related Wet Macular Degeneration

Age-related Wet Macular Degeneration
NCT06115070

Not yet recruiting

Intravenous Thrombolytic Therapy for Acute Ischemic Stroke Patients with Low NIHSS and Non-disabling Deficits (ALLOW)

Thrombosis | Acute Ischemic Stroke (AIS)
NCT05846750

Recruiting

Obinutuzumab in Combination With Lenalidomide in Relapsed or Refractory Marginal Zone Lymphoma

Marginal Zone Lymphoma
NCT05203276

Recruiting

Envafolimab Combined With Endostar in the First-line Treatment of Advanced NSCLC

Lung Neoplasms
NCT04796857

Recruiting

Tislelizumab in Combination With Lenalidomide in Refractory and Relapsed Elderly Patients With Non-GCB DLBCL

High-grade B-cell Lymphoma | Transformed Lymphoma | EBV-Positive DLBCL, Nos | ALK-Positive Anaplastic Large Cell Lymphoma | Non-GCB/ABC Diffuse Large B-Cell Lymphoma | Follicular Lymphoma Grade IIIb
NCT04760301

Recruiting

Local Tranexamic Acid During Vaginal Hysteractomy to Reduce Blood Loss

Blood Loss
NCT04696224

Recruiting

Comparative Use of Tranexamic Acid Intravenous and Topical Application in Intertrochanteric Fractures With PFNA

Hemorrhage | Fracture Femur
NCT04429503

Completed

Study of a High-Dose Aflibercept in Participants With Diabetic Eye Disease (PHOTON)

Type 2 Diabetes Mellitus | Diabetic Macular Edema | Type 1 Diabetes Mellitus
NCT03834753

Completed

A Clinical Effectiveness Study Examining the Efficacy and Safety of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD)

Age-related Macular Degeneration | Wet Macular Degeneration | Neovascular Age-related Macular Degeneration
NCT06667050

Active, not recruiting

CAPOX Plus Sintilimab and Bevacizumab Biosimilar (IBI305) for Neoadjuvant Treatment of Locally Advanced Gastric Cancer

Gastric Adenocarcinoma
NCT02606045

Terminated

Minimize Menorrhagia in Women With Von Willebrand Disease (VWDMin)

Von Willebrand Diseases

Search clinical trials for: Modulation of FiO2

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations